MARKET

BDSX

BDSX

BIODESIX INC
NASDAQ
1.380
-0.090
-6.12%
After Hours: 1.380 0 0.00% 19:22 03/18 EDT
OPEN
1.540
PREV CLOSE
1.470
HIGH
1.540
LOW
1.360
VOLUME
49.28K
TURNOVER
0
52 WEEK HIGH
2.210
52 WEEK LOW
1.030
MARKET CAP
133.78M
P/E (TTM)
-2.1729
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BDSX last week (0311-0315)?
Weekly Report · 15h ago
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
NASDAQ · 4d ago
Weekly Report: what happened at BDSX last week (0304-0308)?
Weekly Report · 03/11 11:13
Biodesix Price Target Maintained With a $3.50/Share by Canaccord Genuity
Dow Jones · 03/04 15:13
Canaccord Genuity Reiterates Buy on Biodesix, Maintains $3.5 Price Target
Benzinga · 03/04 15:04
Weekly Report: what happened at BDSX last week (0226-0301)?
Weekly Report · 03/04 11:16
BUZZ-U.S. STOCKS ON THE MOVE-Madrigal Pharma, Copper miners, NetApp
S&P 500 and Nasdaq climb on Friday as chipmakers extend gains. Dow Jones Industrial Average up 0.17% at 39,060.77. Copper miners, NetApp and Madrigal Pharma are among the day's losers. Treasury yields dip on soft economic data and remarks from Fed officials.
Reuters · 03/01 19:20
BUZZ-Biodesix rises on better-than-expected 2024 revenue
Shares of diagnostic solutions co Biodesix rise 7.1% to $1.65. Co sees 2024 revenue in the range of $65 mln to $68 mln, above analysts' estimates. Reports Q4 revenue of $14.67 mln.
Reuters · 03/01 16:06
More
About BDSX
Biodesix, Inc. (Biodesix) is a data-driven diagnostic solutions company. Biodesix is focused on using technologies with its artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs in lung disease. Biodesix is providing diagnostic testing services associated with blood-based lung tests; coronavirus disease tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development, and testing services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Its blood-based lung cancer tests include Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. Biodesix also offers SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralizing Antibody testing.

Webull offers Biodesix Inc stock information, including NASDAQ: BDSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDSX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDSX stock methods without spending real money on the virtual paper trading platform.